SCHEMBL7426233

SCHEMBL7426233

CCCC[Si](C)(CC[CH]CS(=O)(=O)c1ccc(C)cc1)CCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.44
ALDH1A1 P00352 7/20 0.44
CYP2C9 P11712 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
MCHR1 Q99705 1/20 0.43
GFER P55789 1/20 0.40
LMNA P02545 1/20 0.39
ALB P02768 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 2/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 2/20 0.35
ADAM17 P78536 1/20 0.35
POLB P06746 1/20 0.35
TLR9 Q9NR96 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28223371 0.74 CTSK (0.58) CTSKALDH1A1CYP2C9CYP3A4CYP2C19
SCHEMBL7768688 0.72 TLR9 (0.46) CTSKALDH1A1CYP2C9CYP3A4CYP2C19
SCHEMBL3013104 0.69 ALDH1A1 (0.80) CTSKALDH1A1CYP2C9CYP3A4CYP2C19
SCHEMBL149805 0.69 CTSK (0.44) CTSKALDH1A1CYP2C9CYP3A4CYP2C19
SCHEMBL11038225 0.69 CTSK (0.75) CTSKALDH1A1CYP2C9CYP3A4CYP2C19
SCHEMBL8778830 0.68 ALDH1A1 (0.77) ALDH1A1CYP2C9CYP3A4CYP2C19MCHR1
SCHEMBL28117496 0.68 CTSK (0.43) CTSKALDH1A1CYP2C9CYP3A4CYP2C19
SCHEMBL11024014 0.67 CTSK (0.61) CTSKALDH1A1CYP2C9CYP3A4CYP2C19
SCHEMBL9103003 0.66 ALDH1A1 (0.74) ALDH1A1CYP2C9CYP3A4CYP2C19MCHR1
SCHEMBL9099947 0.66 ALDH1A1 (0.74) ALDH1A1CYP2C9CYP3A4CYP2C19MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261583-A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES Idun Pharmaceuticals, Inc. (US) 2002-12-04 EP disclosed
EP-1210338-A2 1,4-DIAZEPINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE CENTRAL NERVOUS SYSTEM IGT Pharma Inc. (CA) 2002-06-05 EP disclosed
EP-1159291-A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYLCARBONYLDIPEPTIDES AS INHIBITORS OF THE ICE/CED-3 FAMILY OF CYSTEINE PROTEASES Idun Pharmaceuticals, Inc. (US) 2001-12-05 EP disclosed
WO-2001051462-A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES IDUN PHARMACEUTICALS, INC. (US) 2001-07-19 WO disclosed
WO-2001010846-A2 1,4-DIAZEPINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE CENTRAL NERVOUS SYSTEM IGT PHARMA INC. (CA) 2001-02-15 WO disclosed
WO-2001000658-A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYLCARBONYLDIPEPTIDES AS INHIBITORS OF THE ICE/CED-3 FAMILY OF CYSTEINE PROTEASES IDUN PHARMACEUTICALS, INC. (US) 2001-01-04 WO disclosed